Hospitalizations in Europe
As of November 28, the number of hospital inpatients in Europe stood at 90,397. According to data provided by Our World in Data, the European countries that unfortunately admit the most citizens on a daily basis are Poland, where, on average, 476 new hospital admissions are recorded every day, followed by France with 192 admissions per day and the Czech Republic with 116 new admissions per day.
According to data provided by Robert Koch Institut as of 03/12/2021, 10:00 AM, in Germany there has been an increase of 1,786 new hospitalisations with COVID-19, the average incidence over the last 7 days in hospitalised cases is 5.52 per 100,000 population.
Likewise, on 02/12/2021, 4,793 patients with COVID-19 were in intensive care units (ICU), representing 103 more cases compared to the previous day. Therefore, 21.6% of the total number of available intensive care beds were occupied by adults with COVID-19.
*Our World in Data does not provide data on hospitalizations for Germany, the Netherlands, Russia, Romania, Turkey, Greece and Latvia.
Current Vaccination in Europe
As of December 1, 2021, and as of November 30, 2021, an additional 15 cases of SARS-CoV-2 Omicron VOC have been confirmed, bringing the total to 59 confirmed cases. The cases have been reported by 11 European Union and European Economic Area countries : Austria (3), Belgium (2), Czech Republic (1), Denmark (4), France (1, in Réunion), Germany (9), Italy (4), Netherlands (16), Portugal (14), Spain (2) and Sweden (3), according to information from public sources.
Several probable cases have also been reported throughout the region, but are still under investigation. Most of the confirmed cases have traveled to countries in southern Africa, and some have made connections in other destinations between Africa and Europe. All cases for which severity information is available were asymptomatic or mild. To date, no severe cases or deaths have been reported among these cases.
Cases have also been reported in 12 countries and territories outside the EU/EEA: Australia, Botswana, Brazil, Canada, Hong Kong Special Administrative Region, Israel, Japan, Nigeria, Saudi Arabia, South Africa, Switzerland and the United Kingdom.
Statements by Ursula Von der Leyen on compulsory vaccination in the EU
“One third of the European population is not vaccinated: that’s 150 million people. That is a lot. Not everybody can be vaccinated, there are very young children for example, or people with special medical conditions, but the vast majority can be vaccinated. And, therefore, I think it is understandable and appropriate to lead this debate now. How can we encourage and think about the possibility of compulsory vaccination within the EU? This needs to be debated, it needs a common approach but it is a debate that needs to happen.”
We are now facing a double challenge in the fight against #COVID19.
The rapid resurgence of Delta across Europe and a new variant of concern: Omicron.
Full vaccination and boosters provide the strongest protection there is. And they are available now. https://t.co/FOuda4Jbvj
— Ursula von der Leyen (@vonderleyen) December 1, 2021
Since last September, most European countries have started to administer the third booster dose of the COVID-19 vaccine to some sectors of the population. As of November 30, the country in which the largest number of citizens have received the booster dose is Israel, where 43.94% of citizens have already received it. It is followed by Iceland with 39.9% of the population and Hungary with 26.56%.
Below, we show how the administration of the booster dose is progressing in the first twelve countries that have administered the most vaccines of this type in Europe:
|Países||% Dosis completa||% Tercera Dosis|
|Macediona del Norte||37,93||3,03|
|Bosnia and Herzegovina|
Source: Our world in data
Since June 2020, the European Commission has presented a European strategy to accelerate the development, manufacture and deployment of vaccines against COVID-19. An effective and safe vaccine against the virus is the best bet for a permanent solution to the pandemic.
The European Investment Bank (EIB) has reached several financing agreements to support the development of the COVID-19 vaccine programme with pharmaceutical companies, most recently on 23 November when the Valneva #COVID19 vaccine contract was signed. This expands the already extensive portfolio of safe and effective vaccines to be produced in Europe, which includes contracts with AstraZeneca, Sanofi-GSK, Janssen, BioNtech-Pfizer, CureVac, Moderna, and Valneva. It is another key step towards ensuring that Europe is well prepared to deal with the COVID-19 pandemic.
Covid-19 vaccines work. The evidence is now clear: the more vaccination, the lower the risk of death and therefore the fewer deaths. This is once again made clear by a graph produced and published by the European Commission showing the effectiveness of vaccination against the coronavirus, with figures for each country. On one side, the percentage of the population with the full regimen and on the other the number of deaths per million inhabitants in 14 days.
In Spain, to date 37,557,243 people have received the complete COVID-19 vaccination regimen.
Vaccination in Europe
During the month of October Europe reached 478,193,152 vaccinated citizens, which means that 60.24 % of Europe’s inhabitants have already received the full course of one of the licensed vaccines and have therefore already been immunized against COVID-19. During the month of October, a total of 24,463,800 more people in Europe were vaccinated with the full course of vaccines. The rate of vaccination during this month was slower than in September, as 29.1% fewer citizens were vaccinated with the full vaccination schedule in October than in September.
The European countries which, to date, have vaccinated a higher percentage of their citizens are: Portugal (87.17 % of its population vaccinated), Malta (82.99 %), Iceland (81.16 %), Spain (79.83 %), Denmark (75.9 %) and Ireland (75.24 %).
The countries where the pace of vaccination is progressing more slowly to date and have a lower percentage immunized are: Armenia (4.36 %), Ukraine (17.19 %) Belarus (18.53 %) Bosnia and Herzegovina (20.9 %), Moldova (21.7 %) and Bulgaria (21.91 %).
Vaccination in the most populous countries
As for the countries with the largest number of inhabitants in Europe and with the highest percentage of vaccinated population are: Spain (79.83 %), Italy (71.74 %), France (68.01 %), United Kingdom (67.02 %) and Germany (66.14 %).
Hospitalisations in Europe
As of October 31, there were 58,030 hospitalized citizens in Europe, representing an increase of 42.12 % in the number of hospitalized citizens compared to September. The largest increase in the number of hospitalized citizens was in the Czech Republic, where the number of hospitalized citizens increased by 595.83 %, Poland with an increase of 307 %, Hungary with an increase of 197.93 %, the Netherlands with an increase of 195.73 %, Estonia with an increase of 184.76 % and Latvia with an increase of 183.44 %.
The countries where the number of inpatients decreased the most during the month of October were: Israel, where the number of inpatients decreased by 65.4%, Spain with a decrease of 31.4%, Malta where the number of inpatients decreased by 23%, Cyprus with a decrease of 16.43%, and Italy with a decrease of 12.71%.
*Our World in Data does not provide data on hospitalizations in Russia, Turkey, Germany, Ukraine and Romania
Vaccination against COVID-19 started on 27 December 2020 across the European Union, in a moment of unity.
For now, people in priority groups are vaccinated – elderly people or healthcare professionals. But soon there will be enough vaccines for the entire EU population.
Once enough people are vaccinated, we will be able to get our normal lives back, gradually.
Evolution of vaccination in Europe (People +18 y.o.)
|Country||% Fully Vaccinated||% Booster doses|
|Bosnia and Herzegovina|
Statement by President von der Leyen on developments in the Vaccines Strategy
Vaccines authorized by the European Union
|Company||Type of vaccine||Number of doses
(needed per person)
|Number of doses
|BioNTech and Pfizer||mRNA||2 doses||600 million||Approved|
|Moderna||mRNA||2 doses||160 million||Approved|
|CureVac||mRNA||2 doses||405 million||Development ongoing|
|AstraZeneca||adenovirus||2 doses||400 million||Approved|
|Johnson & Johnson/Janssen Pharmaceuticals||adenovirus||1 dose||400 million||Approved|
|Sanofi-GSK||protein||2 doses||300 million||Development ongoing|